HomeCompareVPTDF vs EPRT

VPTDF vs EPRT: Dividend Comparison 2026

VPTDF yields 2312.14% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VPTDF wins by $38613850936.55M in total portfolio value
10 years
VPTDF
VPTDF
● Live price
2312.14%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38613850936.61M
Annual income
$35,586,201,922,515,856.00
Full VPTDF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — VPTDF vs EPRT

📍 VPTDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVPTDFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VPTDF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VPTDF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPTDF
Annual income on $10K today (after 15% tax)
$196,531.79/yr
After 10yr DRIP, annual income (after tax)
$30,248,271,634,138,476.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, VPTDF beats the other by $30,248,271,634,127,560.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPTDF + EPRT for your $10,000?

VPTDF: 50%EPRT: 50%
100% EPRT50/50100% VPTDF
Portfolio after 10yr
$19306925468.34M
Annual income
$17,793,100,961,264,348.00/yr
Blended yield
92.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

VPTDF
No analyst data
Altman Z
-272.5
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPTDF buys
0
EPRT buys
0
No recent congressional trades found for VPTDF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVPTDFEPRT
Forward yield2312.14%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$38613850936.61M$63.4K
Annual income after 10y$35,586,201,922,515,856.00$12,840.73
Total dividends collected$38401207511.77M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: VPTDF vs EPRT ($10,000, DRIP)

YearVPTDF PortfolioVPTDF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$241,914$231,213.87$11,205$505.18+$230.7KVPTDF
2$5,486,310$5,227,462.00$12,672$682.46+$5.47MVPTDF
3$116,667,010$110,796,658.85$14,490$930.48+$116.65MVPTDF
4$2,326,799,779$2,201,966,078.24$16,786$1,282.69+$2326.78MVPTDF
5$43,532,552,320$41,042,876,556.38$19,753$1,791.56+$43532.53MVPTDF
6$764,223,950,336$717,644,119,353.02$23,677$2,541.64+$764223.93MVPTDF
7$12,591,932,032,884$11,774,212,406,024.32$29,008$3,672.99+$12591932.00MVPTDF
8$194,782,556,253,371$181,309,188,978,186.10$36,463$5,425.08+$194782556.22MVPTDF
9$2,829,578,517,848,077$2,621,161,182,656,969.50$47,238$8,221.57+$2829578517.80MVPTDF
10$38,613,850,936,613,300$35,586,201,922,515,856.00$63,385$12,840.73+$38613850936.55MVPTDF

VPTDF vs EPRT: Complete Analysis 2026

VPTDFStock

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.

Full VPTDF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this VPTDF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPTDF vs SCHDVPTDF vs JEPIVPTDF vs OVPTDF vs KOVPTDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.